The Eurotransplant donor risk index in liver transplantation: ET-DRI.
about
How important is donor age in liver transplantation?Deceased donor risk factors influencing liver transplant outcomeEffects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient StatusEvaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era?The corrected donor age for hepatitis C virus-infected liver transplant recipients.Effect of airplane transport of donor livers on post-liver transplantation survival.Prognostic limitations of the Eurotransplant-Donor Risk Index in liver transplantation.A prospective cohort study of risk prediction in simultaneous pancreas and kidney transplantation.Liver-specific deceased donor risk indices.Liver transplantation for acute liver failure: are there thresholds not to be crossed?Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study.A simplified method of calculating cPRA for kidney allocation application in Hong Kong: a retrospective study.The donor risk index: A decade of experience.Morbidity and Mortality Rounds in Liver TransplantationExternal validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry.A systematic review and meta-analysis of cold in situ perfusion and preservation of the hepatic allograft: working towards a unified approach.Eurotransplant donor-risk-index and recipient factors: influence on long-term outcome after liver transplantation - A large single-center experience.Impact of dynamic changes in MELD score on survival after liver transplantation - a Eurotransplant registry analysis.Factors associated with long-term survival after liver transplantation: A retrospective cohort study.Combined effect of donor and recipient risk on outcome after liver transplantation: Research of the Eurotransplant database.MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.High serum Aspartate transaminase levels on day 3 postliver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.Flushing the liver with urokinase before transplantation does not prevent nonanastomotic biliary strictures.De novo hepatitis B virus infection after pediatric liver transplantations with hepatitis B core antibody-positive donors: a single-center 20-yr experience.Elderly donor liver grafts are not associated with a higher incidence of biliary complications after liver transplantation: results of a national multicenter study.Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers.Moving toward the utilization of all donated liver grafts. The "b-list" concept.Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C.Can we match donors and recipients in a cost-effective way?The difficulty in defining extended donor criteria for liver grafts: the Eurotransplant experience.Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience.Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation.[Liver transplantation with living donor : current aspects, perspectives and significance in Germany].Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial.Normothermic machine perfusion of donor livers without the need for human blood products.Graft-derived macrophage migration inhibitory factor correlates with hepatocellular injury in patients undergoing liver transplantation.High Center Volume Does Not Mitigate Risk Associated with Using High Donor Risk Organs in Liver Transplantation.Systematic review and meta-analysis of liver transplantation using grafts from deceased donors aged over 70 years.Pretreatment Donors after Circulatory Death with Simvastatin Alleviates Liver Ischemia Reperfusion Injury through a KLF2-Dependent Mechanism in Rat.First experience of liver transplantation with type 2 donation after cardiac death in France.
P2860
Q26747570-5D9F00AF-8AF5-4665-B61F-058719A18713Q27003929-464FCB18-F74A-450D-AA5C-F605301536C7Q28601900-8B4F7F99-557E-4441-AEC6-4F4528792517Q36147664-A01DC82D-2C18-43B9-8A40-D17768B654F8Q36734395-1A8EB58D-D20C-4ECE-8355-14E359F27B60Q37411312-931871C4-7C92-409D-960B-3C41BB3BEBCAQ37425201-9F9EEC54-D3FA-4FC7-AF33-8F45524D41EFQ37447772-41B256D3-B98F-4F33-AC96-2A5F8A2988F6Q38137275-6A4CED90-2C23-46CB-92FF-12FE17A19E32Q38194205-BE879ED0-A575-4725-8B02-5F9591A31FD7Q38202916-80E7D724-B9E3-43C4-BB2A-2600EDD8634CQ38640905-7721DB03-E2C7-4031-AF5D-EFF03E438C9EQ38738555-5EC72F94-4FC8-48C3-840B-29EB936592FAQ38976828-7E5629A0-1985-404E-9B30-06779B434E44Q38989738-E890B217-EFDC-44E3-856E-697A93CAEEA9Q39451702-9B722972-32F6-4D70-AD14-F88B06D6A8BAQ40015342-D13723AC-27BC-4CF9-96AF-42882CDE9356Q40058139-D29C3D91-D943-4FD3-811B-8F406000E081Q40267665-BFE0E211-34F5-4DED-AB18-7A6AE096FE16Q40625923-2B471714-D97B-4B8E-B60C-84B86178C669Q40693127-04266317-354F-4B49-A8A4-0C7A08F9B50BQ41090808-AE8A561D-AFD0-4541-974A-C1BDAFCE3AF1Q41102006-346F5F2E-07B9-456C-AC1E-BD0AAB3089F6Q41506112-826A0CE1-4F6F-4316-BB50-6C926A75093EQ41724644-F15CEA2D-561D-4A40-A814-E9393DC155EDQ41989619-F20D1784-00D7-4CC2-8584-34D5381052DEQ42162305-6B50BEB4-1A1E-45D9-9E0B-8ED5CF9AAA33Q42233093-8D1C08E1-7AFF-48A4-A234-54B06D5E2DFCQ44586834-5AA206E3-591F-4BAE-A8DB-28CD1C61AB16Q44675883-CFA853CF-A1FB-46A9-8FAE-A1DD0BEB61E9Q45808588-EBC6A16C-648D-4EF2-9E07-C665314C385FQ45952333-F2498505-487D-4AA3-8FE4-AD1A324E316EQ46040254-BC70D271-BD34-4E6D-A0B1-D249754B9D4CQ47147559-35081E3C-93BC-4569-9A07-91EF83410BE9Q47172892-F4E6C072-F1F1-4544-AE97-F136A024DF3CQ47312360-D0FB8077-F857-4BC3-8D92-4092FA9C2CCBQ47724712-551E0634-299D-4D87-8CAE-56EEDF998EBFQ48169076-7EF77CDA-6525-42A1-86E5-C39853F92E8EQ48214383-272D9989-9721-4010-A650-286F17E87423Q48234191-E54A704B-BBBE-424D-B327-260EBE99A62C
P2860
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
@en
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
@nl
type
label
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
@en
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
@nl
prefLabel
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
@en
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
@nl
P2093
P2860
P1476
The Eurotransplant donor risk index in liver transplantation: ET-DRI.
@en
P2093
A K Burroughs
A O Rahmel
European Liver and Intestine T ...... ine Advisory Committee (ELIAC)
P2860
P304
P356
10.1111/J.1600-6143.2012.04195.X
P407
P577
2012-07-23T00:00:00Z